Markets:

Overview

News

Currencies

International

Treasuries

Agenus Inc. - Common Stock (NQ:AGEN)

3.910 +0.160 (+4.27%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Agenus Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Mid-Morning Market Update: Markets Mixed; Walmart Tops Q1 Expectations ↗

May 18, 2021

Following the market opening Tuesday, the Dow traded down 0.23% to 34,248.63 while the NASDAQ rose 0.39% to 13,431.72. The S&P also fell, dropping 0.13% to 4,158.02. The U.S....

Via Benzinga

Topics Stocks

Bristol Myers Inks $1.6B Licensing Agreement For Agenus' Bispecific Antibody Program In Solid Tumors ↗

May 18, 2021

Bristol-Myers Squibb Co (NYSE: BMY) and Agenus Inc (NASDAQ: AGEN) have entered into a global exclusive license agreement, under which Bristol Myers will...

Via Benzinga

Agenus and Bristol Myers Squibb Announce Exclusive Global License for Agenus’ Anti-TIGIT Bispecific Antibody Program

May 18, 2021

From Bristol-Myers Squibb

Via Business Wire

Why Agenus Stock Tumbled Today ↗

May 06, 2021

The company announced mixed Q1 results on a day when many biotech stocks were sinking.

Via The Motley Fool

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

Agenus Inc (AGEN) Q1 2021 Earnings Call Transcript ↗

May 06, 2021

AGEN earnings call for the period ending April 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.